期刊文献+

提高蛋白质和多肽类药物代谢稳定性的研究进展 被引量:7

Progress in the Stability of Protein and Polypeptide Drugs
在线阅读 下载PDF
导出
摘要 蛋白质和多肽类药物在体内存留时间的长短极大地影响到药物的使用剂量和治疗效果。本文综合现有的资料熏对包括蛋白酶的作用、物理和化学变化、给药方式等影响该类药物代谢稳定性的因素以及相应的解决方案作一综述。 The stability of protein polypeptide drugs can greatly influence their, dosage and effectiveness. From documents it can be concluded that protease, physical and chemical changes, receptor mediated elimination route and drug delivery system are the main factors for their instability. Here these factors and related solutions are reviewed.
出处 《生物技术通讯》 CAS 2005年第6期665-667,共3页 Letters in Biotechnology
关键词 多肽药物 半衰期 polypeptide half-life
  • 相关文献

参考文献21

  • 1Mariotti F, Huneau J, Mahe S, et al. Protein metabolism and the gut[J]. Curro Opin Clin Nutr Metab Care, 2000,3(1):45
  • 2Garibotto G, Tessari P, Sacco P, et al. Aminoacid metabolism,substrate availability and the control of protein dynamics in the human kidney[J]. J Nephrol, 1999,12(4):203
  • 3Behr TM, Goldenberg DM, Becker W. Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations[J]. Eur J Nucl Med, 1998,25(2):201
  • 4Bailon P, Berthold W. Polyethlyene glycol conjugated pharmaceutical proteins[J]. PSTT, 1999,1(8):352
  • 5Baker DE. Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C[J]. Med Reviews, 2003,3:92
  • 6He XH, Shaw PC, Xu LH, et al. Site-directed polyethylene glycol modification of trichosanthin: effects on its biological activities,pharmacokinetics, and antigenicity[J]. Life Sci, 1999,64(14):1163
  • 7Sun Xinghua, Yang Zhijian, Li Shukuan, et al. In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5-phosphate supplementation[J]. Cancer Res, 2003,1(63):8377
  • 8Roberts MJ, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation[J]. Adv Drug Deliv Rev, 2002,54(4):459
  • 9Zalipsky S. Functionalized poly polyethlyene glycols for preparation of biologically relevant conjugates[J]. Bioconjugate Chem, 1995,6:150
  • 10Inada Y, Furukawa M, Sasaki H, et al. Biomedical and biotechnological applications of PEG- and PM-modified proteins[J]. Trends Biotechnol, 1995,13(3):86

二级参考文献5

  • 1张海松,陈得光,张宜俊,余宙耀,李屯.HPLC分离测定大鼠血中促肝细胞生长素[J].西北药学杂志,1997,12(2):51-52. 被引量:3
  • 2Fu K,J Control Release,1999年,58卷,3期,357页
  • 3Duan M X,中国药学杂志,1999年,34卷,1期,23页
  • 4Tao W L,蛋白质分子基础,1982年,207页
  • 5方开泰.均匀设计——数论方法在试验设计的应用[J]应用数学学报,1980(04).

共引文献31

同被引文献148

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部